Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01956487 · ClinicalTrials.gov registry record · Phase 1
Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites
A Phase 1 study, sponsored by GlaxoSmithKline.
- Completed
- Registry status
- Phase 1
- Development phase
- 38
- Enrollment target
NCT01956487 is a Phase 1 study that has completed, run by GlaxoSmithKline. The registered enrollment target is 38 participants.
The verdict
NCT01956487, a Phase 1 study, has completed, sponsored by GlaxoSmithKline.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 38 participants
- Enrollment target
Study Summary
Bioequivalence of propafenone hydrochloride capsules manufactured at two different sites
Interventions
- DRUG Propafenone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2012-04-11 |
| Est. Completion | 2012-06-27 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01956487
The ClinicalTrials.gov registry entry for NCT01956487 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Propafenone is the first listed.
NCT01956487 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01956487 about?
NCT01956487 is a clinical study titled "Bioequivalence of RYTHMOL SR® Manufactured at Two Different Sites". Bioequivalence of propafenone hydrochloride capsules manufactured at two different sites
What is the current status of trial NCT01956487?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 38 participants. The study started on 2012-04-11. Estimated completion is 2012-06-27.
What interventions are being tested in trial NCT01956487?
The interventions under investigation include: Propafenone (DRUG).
Who is sponsoring clinical trial NCT01956487?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.